APA

Navas T. A., Nguyen A. N., Hideshima T., Reddy M., Ma J. Y., Haghnazari E., Henson M., Stebbins E. G., Kerr I., O'Young G., Kapoun A. M., Chakravarty S., Mavunkel B., Perumattam J., Luedtke G., Dugar S., Medicherla S., Protter A. A., Schreiner G. F., Anderson K. C. & Higgins L. S. (20061030). Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. : Leukemia.

Chicago

Navas T A, Nguyen A N, Hideshima T, Reddy M, Ma J Y, Haghnazari E, Henson M, Stebbins E G, Kerr I, O'Young G, Kapoun A M, Chakravarty S, Mavunkel B, Perumattam J, Luedtke G, Dugar S, Medicherla S, Protter A A, Schreiner G F, Anderson K C and Higgins L S. 20061030. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. : Leukemia.

Harvard

Navas T. A., Nguyen A. N., Hideshima T., Reddy M., Ma J. Y., Haghnazari E., Henson M., Stebbins E. G., Kerr I., O'Young G., Kapoun A. M., Chakravarty S., Mavunkel B., Perumattam J., Luedtke G., Dugar S., Medicherla S., Protter A. A., Schreiner G. F., Anderson K. C. and Higgins L. S. (20061030). Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. : Leukemia.

MLA

Navas T A, Nguyen A N, Hideshima T, Reddy M, Ma J Y, Haghnazari E, Henson M, Stebbins E G, Kerr I, O'Young G, Kapoun A M, Chakravarty S, Mavunkel B, Perumattam J, Luedtke G, Dugar S, Medicherla S, Protter A A, Schreiner G F, Anderson K C and Higgins L S. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo. : Leukemia. 20061030.